Setting the stage for individualized therapy in hemophilia: What role can pharmacokinetics play?

HCAM Hazendonk; Iris van Moort; RAA Mathot; K Fijnvandraat; Frank Leebeek; PW Collins; Marjon Cnossen

doi:10.1016/j.blre.2018.01.001

Setting the stage for individualized therapy in hemophilia: What role can pharmacokinetics play?

HCAM Hazendonk, Iris van Moort, RAA Mathot, K Fijnvandraat, Frank Leebeek, PW Collins, Marjon Cnossen

Research output: Contribution to journal › Article › Academic › peer-review

49 Citations (Scopus)

35 Downloads (Pure)

Original language	Undefined/Unknown
Pages (from-to)	265-271
Number of pages	7
Journal	Blood Reviews
Volume	32
Issue number	4
DOIs	https://doi.org/10.1016/j.blre.2018.01.001
Publication status	Published - 2018

Research programs

EMC MM-02-54-03

Access to Document

10.1016/j.blre.2018.01.001

REPUB_105534-OA.pdfFinal published version, 415 KB

http://hdl.handle.net/1765/105534

Cite this

@article{cb8f6ae077e04fb288de7cef5a4a7570,

title = "Setting the stage for individualized therapy in hemophilia: What role can pharmacokinetics play?",

author = "HCAM Hazendonk and \{van Moort\}, Iris and RAA Mathot and K Fijnvandraat and Frank Leebeek and PW Collins and Marjon Cnossen",

year = "2018",

doi = "10.1016/j.blre.2018.01.001",

language = "Undefined/Unknown",

volume = "32",

pages = "265--271",

journal = "Blood Reviews",

issn = "0268-960X",